UGT1A1 and Gilbert syndrome: However, patients with Gilbert’s syndrome, caused by a polymorphism in the UGT1A1 gene promoter that results in its protein with reduced activity, have a 2–3 fold increase in plasma bilirubin levels and lower cardiovascular risks [104].